Learn More
As part of our effort in developing a spoken language system for interactive problem solving, we recently collected a sizeable amount of speech data. This database is composed of spontaneous sentences which were collected during a simulated human/machine dialogue. Since a computer log of the spoken dialogue was maintained, we were able to ask the subjects(More)
Cisplatin is a widely used and effective chemotherapeutic agent, although its use is restricted by the high incidence of irreversible ototoxicity associated with it. In children, cisplatin ototoxicity is a serious and pervasive problem, affecting more than 60% of those receiving cisplatin and compromising language and cognitive development. Candidate gene(More)
PURPOSE Anthracycline-induced cardiotoxicity (ACT) is a serious adverse drug reaction limiting anthracycline use and causing substantial morbidity and mortality. Our aim was to identify genetic variants associated with ACT in patients treated for childhood cancer. PATIENTS AND METHODS We carried out a study of 2,977 single-nucleotide polymorphisms (SNPs)(More)
Recently, we initiated a project to develop a phonetically-based spoken language understanding system called SUMMIT. In contrast to many of the past efforts that make use of heuristic rules whose development requires intense knowledge engineering, our approach attempts to express the speech knowledge within a formal framework using well-defined mathematical(More)
BACKGROUND Familial history is a strong risk factor for coronary artery disease (CAD), especially for early-onset myocardial infarction (MI). Several genes and chromosomal regions have been implicated in the genetic cause of coronary artery disease/MI, mostly through the discovery of familial mutations implicated in hyper-/hypocholesterolemia by linkage(More)
AIM The goal of this study was to evaluate the performance of four warfarin pharmacogenetic algorithms in a real clinical setting, namely the algorithms of Gage et al., Michaud et al., Wadelius et al. and the International Warfarin Pharmacogenetics Consortium algorithm. PATIENTS & METHODS Data was obtained retrospectively for 605 patients who had(More)